Skip to main content

What the FDA labels say about taking them together

Clarithromycin and glyburide

Glyburide's FDA label of July 1, 2021 names clarithromycin in its drug interactions section; the clarithromycin label PlainMeds reads does not name glyburide.

Check it at the source: the clarithromycin FDA label on DailyMed (effective April 9, 2026, Solaris Pharma Corporation); the glyburide FDA label on DailyMed (effective July 1, 2021, TEVA Pharmaceuticals USA Inc).

What does the clarithromycin label say about glyburide?

Clarithromycin's label (effective April 9, 2026) does not name glyburide in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Clarithromycin), Solaris Pharma Corporation, effective April 9, 2026 (SPL set 4d42821d-ce7a-7d64-e063-6294a90a0875), via openFDA; the full label on DailyMed

What does the glyburide label say about clarithromycin?

Glyburide label, drug interactions

Drug Interactions The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, ACE inhibitors, disopyramide, fluoxetine, clarithromycin, and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, monoamine oxidase inhibitors, and beta adrenergic blocking agents.

Source: FDA drug label (Glyburide), NDA017532 (Sanofi Aventis Us), as published by TEVA Pharmaceuticals USA Inc, effective July 1, 2021 (SPL set 50d16f1d-c814-4411-8749-62561321ecce), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

26Clarithromycin generic labelers
16Glyburide generic labelers
ClarithromycinGlyburide
Labeled forBacterial infections, Acid reflux and ulcersType 2 diabetes
Boxed warningNoNo
Pharmacy cost (NADAC)$0.466 per tablet 500 mg tablet$0.0643 per tablet 5 mg tablet
Shortage nowNo current entryA presentation being discontinued

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?